ArticlePloS one2015

Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Murali K Ravoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.